LONDON) GOVUK Press Release Statement Report: India’s fight against a surge in #coronavirus cases will be reinforced by new Government support announced by the Boris Johnson today #AceHealthDesk report

#AceHealthReport – May.05: This is in addition to 200 ventilators, 495 oxygen concentrators and 3 oxygen generation units the UK announced we were sending to India last week:

#CoronavirusNewsDesk – NEW DELHI: India’s fight against a surge in #COVID19 cases will be reinforced by addtional UK Government support announced by the Prime Minister today with another 1,000 ventilators will be sent from the UK’s surplus supply to Indian hospitals after the first batch arrived to help the most severe cases as figure reaches 2-million infections on Tuesday’

  • The UK will send 1,000 more ventilators for use in India’s hospitals
  • The Chief Medical Officer, Chief Scientific Adviser and NHS staff have given help and advice to their Indian counterparts
  • Fresh assistance follows medical relief sent by the UK last week and a surge in support from the British people to India
  • On Tuesday the Prime Minister will hold a virtual meeting with Indian Prime Minister Modi to discuss deepening cooperation between the UK and India

Chief Medical Officer Chris Whitty and Chief Scientific Adviser Patrick Vallance have also spoken to their Indian counterparts to provide advice, insight and expertise to the Indian healthcare system as it deals with the world’s worse surge in Covid levels.

NHS England is also establishing a clinical advisory group led by Chief People Officer Prerana Isaar to support India’s Covid response. The group will work with Indian institutions such as the All India Institute of Medical Sciences to share experience on managing Covid outbreaks. The group will include researchers in public and global health, alongside nursing and other health professionals who have experience of the Indian healthcare system.

In a powerful demonstration of what Indian Prime Minister Modi has called the ‘living bridge’ between our countries, over the last week British people have come to the support of India in huge numbers. Businesses, civil society and the wider public have responded to appeals for help and launched funding drives.

This includes the British Asian Trust’s ‘Oxygen for India’ emergency appeal, which is raising funds for oxygen concentrators to be rapidly deployed to Indian hospitals. The BAT appeal, which has been personally backed by the Prince of Wales, has raised more than £1.5m in the last week.

Virgin Atlantic also flew 200 boxes of oxygen concentrators to Delhi on Saturday, after partnering with Khalsa Aid. Further cargo space will be given free of charge on 6 flights to India in the next week, in association with The Red Cross.

India has also provided support to the UK throughout the coronavirus pandemic. As the ‘pharmacy of the world’ the country has kept its borders open to supply the UK with vital medicine and PPE – exporting over 11 million face masks and 3 million packets of paracetamol over the course of 2020.

On Tuesday the Prime Minister will hold a virtual meeting with Prime Minister Modi to agree a huge range of commitments to deepen cooperation between the UK and India, including on fighting the coronavirus pandemic.

Prime Minister Boris Johnson said:

The terrible images we have seen in India in recent weeks are all the more powerful because of the close and enduring connection between the people of the UK and India.

I am deeply moved by the surge of support the British people have provided to the people of India and am pleased the UK Government has been able to play our part in providing life-saving assistance.

The UK will always be there for India in its time of need.

The world is safer and stronger because of work between the UK and India. The Oxford-AstraZeneca vaccine, for example, was developed in the UK, is currently being produced in the millions by India’s Serum Institute and will be distributed to the world at cost through COVAX.

It is those shared values of openness and the pursuit of knowledge and scientific advancement for the betterment of our societies that lie at the heart of the relationship between the UK and India. During his call with Prime Minister Modi, the Prime Minister will emphasise the importance of working with India to promote our shared values.

India is the largest democracy in the world, a fellow Commonwealth country and in June Prime Minister Modi will travel to the UK to attend the G7 Summit as a guest – one of four world leaders invited to join the Summit of leading democracies.

Foreign Secretary Dominic Raab said:

This support will help urgently meet some of India’s acute needs, particularly oxygen for patients. We are determined to help our Indian friends in their hour of need.

We need to all work together to defeat Covid-19. No one is safe until we are all safe.

Further information

A number of other UK charities are running their own appeals for India’s Covid crisis, including ActionAid, Action Against Hunger, the British Red Cross, CAFOD, CARE International, Christian Aid, Concern, Age UK, Islamic Relief, Oxfam, Plan UK, Save the Children, Tearfund and World Vision.

#AceHealthDesk report …..Published: May.05: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#govuk, #india, #london

(LONDON) GOVUK Statement Report: Health Secretary Matt Hancock Sends letter to JCVI after they recommend that adults living with adults who are immunosuppressed should be prioritised for the #COVID19 vaccine

#AceHealthReport – Mar.30: The Joint Committee on Vaccination and Immunisation (JCVI) has advised the government to prioritise people for the coronavirus (COVID-19) vaccine who are over 16 and living with adults who have weakened immune systems, such as those with blood cancer, HIV or those on immunosuppressive treatment including chemotherapy:

#CoronavirusNewsDesk – New vaccine advice for adults living with adults who are immunosuppressed: ‘JCVI recommends that adults living with adults who are immunosuppressed should be prioritised for the #COVID19 vaccine’

Adults who are immunosuppressed have a weaker immune system, meaning they are less able to fight infections naturally. These individuals are more likely to have poorer outcomes following COVID-19 infection and recent evidence suggests that they may not respond as well to the COVID-19 vaccine as others.

There is growing evidence that the COVID-19 vaccines may reduce the chance of someone who has been vaccinated passing the virus on. Given this emerging evidence, the JCVI advises that those over 16 years of age who live with severely immunosuppressed adults are offered the COVID-19 vaccination alongside priority group 6. This will help limit the spread of the virus to immunosuppressed adults.

Professor Wei Shen Lim, Chair of COVID-19 Immunisation within the JCVI, commented:

The vaccination programme has so far seen high vaccine uptake and very encouraging results on infection rates, hospitalisations and mortality. Yet we know that the vaccine isn’t as effective in those who are immunosuppressed. Our latest advice will help reduce the risk of infection in those who may not be able to fully benefit from being vaccinated themselves.

Dr Mary Ramsay, Head of Immunisation at Public Health England, said:

Our surveillance systems and research studies are showing that the COVID-19 vaccines can reduce asymptomatic infection and limit transmission of the virus. By vaccinating those who live with adults who are immunosuppressed, we can further help protect vulnerable people.

Household contacts considered as a priority would be those over 16 who share living accommodation with adults who are immunosuppressed. The JCVI does not currently advise vaccination of household contacts of immunosuppressed children, or household contacts of immunosuppressed adults who are themselves children.

Letter from the Health and Social Care Secretary to the JCVI: 24 March 2021

From:Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care
39 Victoria Street
London
SW1H 0EU

To:Professor Wei Shen Lim
Joint Committee on Vaccination and Immunisation
Chair COVID-19 Immunisation (Nottingham University Hospitals)

24 March 2021

Dear Professor Lim,

Thank you for your letter on 24 March from the Joint Committee on Vaccination and Immunisation (JCVI) with your advice about COVID-19 vaccination of adult household contacts of severely immunosuppressed adults.

I note your findings that early data indicate lower protection in vaccinated adults who are immunosuppressed and that those with severe immunosuppression are therefore more likely to suffer poor outcomes following infection and are less likely to benefit from the vaccines offered.

I also note your advice that there is now data indicating the potential for a reduction in transmission in those vaccinated. I welcome your advice that adult household contacts of adults with severe immunosuppression should be offered COVID-19 vaccination alongside priority group 6 on the basis that this would in your view reduce the risk of infection in the immunosuppressed who may not be able to fully benefit from vaccination.

I am asking NHS England and Improvement (NHSE/I) to take this advice forward and prioritise household contacts of the severely immunosuppressed for vaccination as you recommend alongside priority group 6 in phase 1 of the vaccination programme.

My officials have also shared your advice with colleagues leading the COVID-19 vaccines programmes in each of the 4 nations of the UK.

Thank you for your continued advice and support for the vaccination programme and I look forward to receiving further advice and discussions over the coming weeks.

Yours ever,

Matt Hancock

Cc: Professor Jonathan Van-Tam (DCMO)

#AceHealthDesk report ……….Published: Mar.30: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#govuk, #health, #jcvi, #london

(LONDON) GOVUK Press Statement Report: A new study led by Sheffield & Oxford Universities with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against #COVID19 after just one dose of the Pfizer vaccine #AceHealthDesk report

#CoronavirusNewsDesk – New study finds strong immune response following #COVID19 vaccination: ‘Study led by Sheffield and Oxford Universities finds that 99% of people have robust immune response against COVID-19 after one dose of Pfizer vaccine’

  • 237 healthcare workers tested for antibody and T cell responses, as part of the largest and most in-depth study on the immune response following COVID-19 vaccination
  • First findings from DHSC-funded PITCH study shows one dose of the Pfizer vaccine generates robust T cell and antibody responses in 99% of people
  • Study shows people who have previously had COVID-19 generate stronger T cell and antibody responses following one dose of the Pfizer vaccine

A new study led by Sheffield and Oxford Universities with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine.

The Protective Immunity from T cells to COVID-19 in health workers study (PITCH) examined how the immune system responds to COVID-19 after one dose of the Pfizer vaccine among people who have been infected by COVID-19 before and those who have not.

It suggests one dose of the vaccine protects against severe disease, supporting the decision to delay the second dose and provide protection to as many higher-risk groups as possible by providing more first doses. The study showed after 2 doses levels of protection were even stronger, underlining the importance of people coming forward for their second dose.

Between 9 December 2020 and 9 February 2021, researchers from the Universities of Sheffield, Oxford, Liverpool, Newcastle and Birmingham analysed blood samples from 237 healthcare workers to understand their T cell and antibody responses following vaccination from the Pfizer vaccine.

The study also sheds light on the impact of previous infection from COVID-19 on people’s immune response to vaccination. It found people who had previously been infected with COVID-19 showed higher T cell and antibody responses after one dose of the Pfizer vaccine compared with people who had never had COVID-19 before and had one dose of the vaccine.

The researchers discovered that among people who had had COVID-19 in the past, the T cell response expanded after vaccination to recognise more regions of the COVID-19 spike protein – which attacks the immune system and causes severe disease. This means, even in those already infected, vaccination from the Pfizer jab provides better protection and an enhanced immune response to COVID-19 than the immune response from natural infection.

It is not yet known how long T cell and antibody response lasts following infection. The first dose of both the Pfizer and AstraZeneca vaccine offer good levels of protection, but to get maximum protection it is vital everyone gets a second dose when invited as 2 doses of the vaccine will provide longer-lasting protection from the virus.

Health and Social Care Secretary Matt Hancock said:

The PITCH study presents further proof that vaccines provide excellent protection against the virus. Thanks to the incredible efforts of our vaccination programme, over half of all adults in the UK have had the jab, and we remain on track to offer all adults a vaccine by the end of July.

A second vaccine jab is crucial for longer-term protection, regardless of whether you have previously had COVID-19 or not, and I urge everyone to make sure they attend their second appointment – to keep themselves and those around them safe.

Health Minister Lord Bethell said:

These findings from the PITCH study are crucial to increasing our understanding of the immune response to COVID-19 and how the Pfizer vaccine is working to protect people across the UK already.

I urge everyone to come forward to be vaccinated when invited and to take up both doses of the vaccine as both are vital to ensuring long-term protection from COVID-19.

Key findings from the PITCH study

  • Among individuals who had not had COVID-19 in the past and had received 2 doses of the Pfizer vaccine, T cell response was as strong as people who had had previous COVID-19 infection and one vaccine dose.
  • After one dose of the Pfizer vaccine, individuals who had previous COVID-19 infection showed higher antibody and T cell responses compared with people who had not been infected before. Antibody responses were 6.8 times higher and T cell responses 5.9 times higher.
  • Among individuals who had not had COVID-19 in the past and had received one dose of the Pfizer vaccine, antibody and T cell responses were at a similar or higher level compared to those who had previously been infected but not been vaccinated.
  • There was a 10-fold greater spike-specific T cell responses following vaccination in people with previous infection compared to those who had no prior infection.
  • There was no link between age and levels of T cell/antibody response.

An effective vaccine is one that that saves lives and reduces hospitalisations. Both the Pfizer and Oxford-AstraZeneca vaccines have been shown to be highly effective in reducing COVID-19 infections among older people aged 70 years, according to previously published research carried out by Public Health England. In the over 80s, data suggest that a single dose of either vaccine is more than 80% effective at preventing hospitalisation, around 3 to 4 weeks after the jab.

Further research will continue to deepen our understanding of the immune responses over the longer term and what it means for protection against COVID-19 in the real world.

Even after vaccination everyone must continue to follow the rules – remembering Hands, Face, Space – as it may still be possible to pass the virus on to others after having the jab.

Dr Thushan de Silva, study author from the University of Sheffield, said:

Our study is one of the largest and most comprehensive accounts of the immune response to one dose of Pfizer/BioNTech vaccine comparing previously infected and infection-naive individuals. Our results demonstrate that T cell and antibody responses induced by natural infection are boosted significantly by a single dose of vaccine. While the response to a single dose was lower in infection-naïve individuals, it was still equivalent or better than the immunity in previously infected individuals before it is boosted by vaccination.

Professor Susanna Dunachie, PITCH study lead from the University of Oxford, said:

Our study highlights the importance of studying both aspects of immune protection when trying to understand the underlying mechanisms of the immune response to COVID-19 vaccination. Interestingly, we also found that vaccination improves the breadth of T cell responses generated in previously infected individuals. In immunology, this is a good thing as it means that you are more likely to maintain protection against new mutations of the virus, and further work will assess how long these vaccine responses last. It’s still important that everyone follows NHS guidelines to get 2 doses of the vaccine, even if you think you may have previously had COVID-19.

The PITCH study has been a great opportunity to work collaboratively across 5 university hospitals and with Public Health England to look at T cell responses to SARS-CoV-2 at greater scale and depth than a single research centre can. By building on the national SIREN Study and putting our heads together, we are contributing towards illuminating the role of T cells in protection against COVID-19 from vaccines and previous infection.

Professor Paul Klenerman, PITCH study lead from the University of Oxford, said:

T cells are an important component of immunity to viruses – but typically much harder to measure than antibodies. To set this up at scale across the UK in the midst of a pandemic was a big challenge but the very clear data found by PITCH show just how informative this approach can be.

Background information

See the pre-print report on T cell and antibody responses available on the Lancet website

This study formed part of the PITCH Study (Protective Immunity from T-cells in Healthcare workers), which was funded by the UKs Department of Health and Social Care. A contribution was also made from the UK Coronavirus Immunology Consortium (funded by UK Research and Innovation and the National Institute for Health Research).

Of the 237 healthcare workers, 113 had previously been infected with COVID-19 compared to 124 healthcare workers who had not. For those who had not previously had COVID-19, 103 were given one dose of the vaccine and 21 were given 2 doses, with a gap of 23 days between doses. The researchers took blood samples from participants prior to and 28 days after vaccination to measure various aspects of the immune response, including antibodies and T cells.

A range of analyses were used to examine aspects of the T cell response including the magnitude of response and the response to different proteins from SARS-CoV-2. Carrying out these T cell analyses is much more complex than antibody studies and difficult to undertake at scale – but this study is the largest and most in depth in the world to date in this field.

References

  • Polack et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine 2020; 383(27): 2603-15.
  • Hall et al. Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020. medRxiv 2021: 2021.01.13.21249642.

#AceHealthDesk report ……Published: Mar.29: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#govuk, #london, #vaccine

(LONDON) GOVUK DHSC Press Statement Report: Package of localised support for those self-isolating receives new cash injection of £12.9-million per month for local authorities #AceHealthDesk report

#AceHealthReport – Mar.27: This new funding will help local authorities continue to support those who are isolating as we begin to cautiously ease restrictions, going towards access to food, help with caring responsibilities and support for people’s wellbeing:

#CoronavirusNewsDesk – Government increases support for those self-isolating: ‘To help people overcome the practical challenges of being asked to self-isolate, government has today (Friday 26 March) announced an extra £12.9 million a month in additional funding to local councils to help them provide people with more support’

  • Improved support includes a free medicines delivery service backed by an extra £3.2 million per month, new practical support funding and enhancements to Test and Trace Support Payment Scheme
  • New ONS survey reveals nearly 90% of people are self-isolating when asked to

On top of this, £3.2 million per month has been allocated to a free medicines delivery service for people who are self-isolating and don’t have access to help in collecting their prescription. Community pharmacies and dispensing doctors are already funded to provide a medicines delivery service in instances where shielding advice is in place, and this system is being replicated to cover people who need to self-isolate.

This investment comes on top of increased funding of £20 million per month for local authorities, which covers the cost of discretionary support payments through the Test and Trace Support Payment scheme (TTSP) for people on lower incomes, or facing financial hardship, who cannot work from home.

The TTSP scheme has also recently been expanded to cover parents or guardians who are unable to work because they are caring for a child who is self-isolating. To date, the government has provided more than £176 million of funding to local authorities to meet the costs of the scheme. This will allow local authorities to continue supporting those on low incomes to stay at home and self-isolate when required to do so.

The announcement comes as a new set of statistics published by the Official of National Statistics (ONS) show that 86% of people testing positive for coronavirus are fully complying with self-isolation guidance for their full isolation period.

Data showed 90% of the contacts reached by NHS Test and Trace are fully adhering with the rules, and 97% of NHS COVID-19 app users started to self-isolate within 24 hours of receiving a notification.

Health and Social Care Secretary Matt Hancock said:

I am delighted that today’s statistics show the vast majority of people in this country are doing the right thing and following the rules to help protect the NHS, and save lives.

The government has increased funding for local authorities by over £30 million a month to give financial and practical support to those who have to self-isolate, helping them to avoid spreading the disease to their communities.

Around one in three have the virus without symptoms, so it is vital those who are asked to self-isolate by NHS Test and Trace do so to turn the table on this terrible virus.

The statistics demonstrate that the majority of respondents also fully understood the self-isolation guidance. Of people who did not fully-comply, the most common breaches were to buy food, collect medicines or to attend medical appointments, which today’s funding will help Local Authorities to address.

Executive Chair of NHS Test and Trace, Baroness Harding said:

It’s extremely encouraging to see that 86% of people testing positive for Covid-19 and 90% of contacts are fully complying with the self-isolation guidance, which is imperative to the success of NHS Test and Trace as we are reaching more people than ever before. The increased support is important to offer additional reassurance to people to come forward for testing and keep breaking the chains of transmission.

Local councils have a fundamental role to play in tackling outbreaks and we are supporting them by giving people the tools they need to stay at home.

It is vital that there are strong local, regional and national partnerships to support people to understand and comply with the guidance and regulations in place that protect their health and save lives.

Background information

See Coronavirus and self-isolation after testing positive in England: 1 February to 13 February 2021.

  • This survey was specifically designed to obtain information on people who have tested positive for COVID-19 and who are at the end of their 10-day self-isolation period.
  • Estimates presented in this release are based on the 2,552 responses received and are not representative of the population testing positive for COVID-19 on the day of being sampled. Respondents were randomly sampled through the Contact Tracing and Advice Service (CTAS) database, held by NHS Test and Trace. This list was created by NHS Test and Trace to record information about people who have tested positive for COVID-19 and their contacts.
  • The statistics presented are experimental statistics, so care needs to be taken when interpreting them. While the sample was stratified to be regionally representative of the population being sampled, people who did not respond to the survey may have been less adherent than those who did, leading to bias in the results. This has an impact on the level of certainty of this research.
  • Future waves of the survey will provide statistics that are weighted to be representative of the population testing positive in the month prior to the survey.

Further background

  • Funding unveiled today was set out in the roadmap.
  • It is a legal duty to self-isolate if you have been instructed to do so by NHS Test and Trace. Any breaches of self-isolation may result in a Fixed Penalty Notice, ranging from £1000 to £10,000.
  • We are working with England’s 314 local authorities to monitor the effectiveness of the Test and Trace Support Payment scheme – including any impact on groups who may be ineligible for it.
  • In conjunction with the Test and Trace Support Payment scheme, local authorities can make additional discretionary payments to anyone facing financial hardship. Local authorities are responsible for the criteria used for discretionary payments in their area.
  • Four million people could be eligible for the Test and Trace Support Payment, which is a targeted scheme to help people on low incomes who cannot work from home, if they are required to self-isolate when they test positive or are identified as a contact.
  • To be eligible under the expansion to a parent or guardian, applicants must need to take time off work to care for a child who is self-isolating. They do not need to have been told to self-isolate by NHS Test and Trace, but they must meet all the other eligibility criteria for a Test and Trace Support Payment or discretionary payment.
  • More details are available on who is eligible for the Test and Trace Support Payment scheme.
  • If an individual is eligible for either the Test and Trace Support Payment or discretionary payment, they will receive the £500 payment as an up-front lump sum on top of any benefits and Statutory Sick Pay that they are currently eligible for.
  • When the scheme launched, the government made an initial £50 million available to local authorities to cover the cost of administering the scheme. This included £15 million for discretionary payments to people who fall outside the scope of the main scheme but who will still face hardship if they have to self-isolate. To date, we have released a total of £176 million to local authorities to enable them to continue administering the scheme. This includes £75 million for discretionary payments.
  • People who are not eligible for a Test and Trace Support Payment may be eligible for other forms of support such as Universal Credit or New Style Employment and Support Allowance.
  • People who are required to self-isolate may receive Statutory Sick Pay (SSP) if they meet the eligibility criteria. See details on who is eligible for SSP.
  • The Test and Trace Support Payment scheme is for England only. There are equivalent schemes in place in Scotland, Wales and Northern Ireland and we are working closely with the devolved administrations to share learning and monitor the impact of the financial support that is available.
  • We need all employers to act responsibly to help their employees work from home wherever possible, and where it isn’t to ensure workplaces are COVID-secure. We are also rolling out rapid-testing helping workers who need to leave home for work during lockdown to continue to do so, while quickly identifying those who may be carrying the virus to stop the spread.
  • The Contain Outbreak Management Fund (COMF) provides funding to local authorities (LAs) in England to be used for test, trace and contain activity in order to reduce the spread of coronavirus in their area.
  • This funding, worth over £225 million per month during the National Lockdown, can be used by English local authorities to fund local coronavirus response public health activities, such as additional contact tracing, testing for hard-to-reach groups, non-financial support for those self-isolating and public health communications.

#AceHealthDesk report ……..Published: Mar.27: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#dhsc, #govuk, #health, #self-isolating

(LONDON) GOVUK Statement Report: The UK on 16 March 2021 reached agreement with Norway and the European Union on catch limits in 2021 for six jointly-managed fish stocks in the North Sea #AceNewsDesk report

‘GOVUK agrees fishing catch limits with EU and Norway: The UK, Norway and the European Union have today signed a trilateral agreement on catch limits in 2021’

The agreement promotes the sustainable management and long-term viability of cod, haddock, plaice, whiting, herring, and saithe stocks in the North Sea. The catch levels agreed for 2021 are worth over £184 million to the UK fishing industry.

This is the first time the UK has participated in the talks as an independent coastal State. Throughout negotiations the UK has pressed for catch limits – known as total allowable catches – to be set sustainably to ensure the long-term future of the fisheries industry.

Fisheries Minister Victoria Prentis said:

Today we successfully concluded the first trilateral fisheries negotiations between the UK, EU and Norway.

As an independent coastal state we are committed to managing our fisheries sustainably, to the benefit of the fishing industry across the UK and our marine environment, now and in the years to come.

UK Government Minister for Scotland David Duguid said:

For the first time in decades we have concluded our first trilateral negotiations with the EU and Norway as an independent coastal state.

The outcome represents an increase in the total allowable catch of certain key stocks for Scotland – such as Haddock and Whiting.

Agreements have also been made which safeguard the long-term viability of some other key stocks such as cod.

We remain committed to supporting the industry and being a champion for our coastal communities on the world stage.

Of the stocks jointly-managed with the EU and Norway, five out of six have been set in line with or lower than the catch level advised by ICES, the International Council for the Exploration of the Sea. This results in catch reductions for North Sea cod (-10%), plaice (-2%), saithe (-25%) and herring (-7.4%) compared with 2020, but increases in haddock (+20%) and whiting (+19%).

The agreed catch limit for haddock is well within the sustainable limits advised by the scientific body ICES. This will encourage the recovery of other key stocks in the North Sea mixed fishery.

North Sea cod will be subject to a slightly smaller reduction than the -16.5% recommended by ICES. The three parties supported this approach as it would allow the stock to recover at a similar pace to that set out in the scientific advice. Furthermore, the catch limit is accompanied by the UK’s ongoing cod avoidance plan which applies to all vessels in UK waters. The plan establishes measures to support the long-term recovery of the stock in UK waters, these include ‘real-time closures’ to protect high abundances of cod and selective fishing gear.

The UK Government has worked closely throughout the negotiations with the Scottish Government and other administrations to reach this consensus.

This trilateral agreement marks the conclusion of the first in a series of annual fisheries negotiations. Bilateral negotiations are underway with the EU, Faroes Islands and Norway to confirm access arrangements and quota exchanges, where applicable.

#AceNewsDesk report ………Published: Mar.18: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#agreement, #european-union, #fishing, #food, #govuk, #norway